Shareholder Votes

LAS VEGAS SANDS CORP shareholders approved Advisory (Non-Binding) Vote on Executive Compensation at the 2026-05-14 meeting.

“Votes to approve an advisory (non-binding) resolution on executive compensation were as follows:”

LAS VEGAS SANDS CORP shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-14 meeting.

“Votes to ratify the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, were as follows:”

LAS VEGAS SANDS CORP shareholders approved Election of Mark Besca, Irwin Chafetz, Micheline Chau, Patrick Dumont, Charles D. Forman, Lewis Kramer, Alain Li and Micky Pant to serve on the Board of Directors until the 2027 Annual Meeting of Stockholders at the 2026-05-14 meeting.

“Votes regarding the election of Mark Besca, Irwin Chafetz, Micheline Chau, Patrick Dumont, Charles D. Forman, Lewis Kramer, Alain Li and Micky Pant to serve on the Board of Directors until the 2027 Annual Meeting of Stockholders, were as follows:”

ENSIGN GROUP, INC shareholders approved Advisory approval of compensation paid to named executive officers at the 2026-05-13 meeting.

“The compensation paid to the Company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, was approved on an advisory basis, and the voting results were as follows:”

ENSIGN GROUP, INC shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for year ending December 31, 2026 at the 2026-05-13 meeting.

“The selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 was ratified, and the voting results were as follows:”

ENSIGN GROUP, INC shareholders approved Election of Class I and Class II directors at the 2026-05-13 meeting.

“The four nominees named below were elected to serve as Class I or Class II directors of the board of directors, as set forth below, to serve until the 2029 and 2027 Annual Meetings, respectively, or until a successor is elected and qualified, and the voting results were as follows:”

Dorman Products, Inc. shareholders approved Approval of Dorman Products, Inc. 2026 Omnibus Incentive Plan at the 2026-05-15 meeting.

“The Dorman Products, Inc. 2026 Omnibus Incentive Plan was approved based on upon the following votes:”

Dorman Products, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for 2026 at the 2026-05-15 meeting.

“The appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2026 was ratified based upon the following votes:”

Dorman Products, Inc. shareholders approved Advisory vote on named executive officer compensation at the 2026-05-15 meeting.

“The compensation of the Company’s named executive officers, as described in the proxy statement, was approved on an advisory basis based upon the following votes:”

Dorman Products, Inc. shareholders approved Election of eight directors at the 2026-05-15 meeting.

“The following nominees were each elected to serve as director for a term of one year to expire at the next annual meeting of shareholders and until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal based upon the following votes:”

QUAINT OAK BANCORP, INC. shareholders approved To ratify the appointment of S.R. Snodgrass, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-05-13 meeting.

“2. To ratify the appointment of S.R. Snodgrass, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026: FOR AGAINST ABSTAIN 1,593,196 9,039 1,612”

QUAINT OAK BANCORP, INC. shareholders approved Election of directors for a three-year term expiring in 2029 at the 2026-05-13 meeting.

“1. Election of directors for a three-year term expiring in 2029: Number of Votes Name of Nominees FOR WITHHELD BROKER NON-VOTES James J. Clarke, Ph.D. 1,089,319 60,200 454,028 William R. Gonzalez, MBA 1,085,876 63,943 454,028 Susan M. Vettori 1,045,739 104,080 454,028”

Ultragenyx Pharmaceutical Inc. shareholders approved Advisory (Non-Binding) Vote to Approve Executive Compensation at the 2026-05-14 meeting.

“Proposal No. 4 – Advisory (Non-Binding) Vote to Approve Executive Compensation At the Annual Meeting, the Company’s stockholders voted, on an advisory basis, in favor of a resolution approving the compensation the Company pays to its “named executive officers” as described in the Proxy Statement. The votes on Proposal 4 were as follows: Votes For Votes Against Abstentions Broker Non-Votes 70,945,277 2,594,517 34,704 11,211,890”

Ultragenyx Pharmaceutical Inc. shareholders approved Ratification of Selection of Independent Registered Accounting Firm at the 2026-05-14 meeting.

“Proposal No. 3 – Ratification of Selection of Independent Registered Accounting Firm At the Annual Meeting, the Company’s stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. The votes on Proposal 3 were as follows: Votes For Votes Against Abstentions 84,551,399 221,802 13,187”

Ultragenyx Pharmaceutical Inc. shareholders approved Approval of the Third A&R 2023 Plan at the 2026-05-14 meeting.

“Proposal No. 2 – Approval of the Third A&R 2023 Plan At the Annual Meeting, the Company’s stockholders approved the Third A&R 2023 Plan. The votes on Proposal 2 were as follows: Votes For Votes Against Abstentions Broker Non-Votes 50,659,150 22,888,600 26,748 11,211,890”

Ultragenyx Pharmaceutical Inc. shareholders approved Election of Class I Directors at the 2026-05-14 meeting.

“Proposal No. 1 – Election of Class I Directors At the Annual Meeting, the Company’s stockholders elected the Class I director nominees below to the Company’s Board of Directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. The votes on Proposal 1 were as follows: Class I Director Nominees Votes For Votes Withheld Broker Non-Votes Emil D. Kakkis, M.D., Ph.D. 72,517,613 1,056,885 11,211,890 Shehnaaz Suliman, M.D. 65,801,638 7,772,860 11,211,890 Daniel G. Welch 66,301,426 7,273,072 11,211,890”

SUN COMMUNITIES INC shareholders approved Ratification of Selection of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-12 meeting.

“Shareholders ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows: Votes For Votes Against Abstentions 115,040,952 408,227 8,392”

SUN COMMUNITIES INC shareholders approved Non-binding Advisory Vote on Executive Compensation at the 2026-05-12 meeting.

“Shareholders approved the non-binding advisory vote on executive compensation, as follows: Votes For Votes Against Abstentions Broker Non-Votes 105,847,022 7,109,561 16,121 2,484,867”

SUN COMMUNITIES INC shareholders approved Election of nine directors to serve until the 2027 Annual Meeting of Shareholders at the 2026-05-12 meeting.

“Shareholders elected nine directors to serve until the 2027 Annual Meeting of Shareholders and until their successors shall have been duly elected and qualified, or their earlier resignation or removal , as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Tonya Allen 102,364,056 10,038,491 570,157 2,484,867 Meghan G. Baivier 110,368,918 2,569,812 33,974 2,484,867 Jeff T. Blau 111,957,751 992,053 22,900 2,484,867 Mark A. Denien 103,430,977 9,391,061 150,666 2,484,867 Jerome W. Ehlinger 111,070,433 1,820,456 81,815 2,484,867 Brian M. Hermelin 109,998,364 2,951,172 23,168 2,484,867 Craig A. Leupold 112,434,399 456,582 81,723 2,484,867 Gary A. Shiffman 108,655,078 4,168,497 149,129 2,484,867 Charles D. Young 112,515,683 435,167 21,854 2,484,867”

Mastech Digital, Inc. shareholders approved Non-binding advisory vote on compensation of named executive officers at the 2026-05-13 meeting.

“Proposal 3 — A non-binding advisory vote on the compensation of the named executive officers of the Company: Votes For Votes Against Abstentions Broker Non-Votes 9,313,024 782,645 5,837 0”

Mastech Digital, Inc. shareholders approved Approval of the Second Amendment to the Stock Incentive Plan to allow for issuance of RSUs at the 2026-05-13 meeting.

“Proposal 2 — Approval of the Second Amendment to allow for the issuance of restricted stock units (“RSUs) under the Plan : Votes For Votes Against Abstentions Broker Non-Votes 9,377,383 721,473 2,650 0”

Mastech Digital, Inc. shareholders approved Election of two Class III directors at the 2026-05-13 meeting.

“Proposal 1 — Election to the Company’s Board of Directors of two (2) Class III directors to serve for three-year terms or until their respective successors shall have been elected and qualified: Nominee Votes For Votes Broker Withheld Non-Votes Arun Nayar 9,498,274 603,232 0 Srinivas Kandula 9,423,712 677,794 0”

ICU MEDICAL INC/DE shareholders rejected Approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. at the 2026-05-13 meeting.

“Proposal 7. Approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Votes For Votes Against Votes Abstained Broker Non-Votes 9,009,640 13,124,012 10,661 1,979,477 The Company’s stockholders did not approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right.”

ICU MEDICAL INC/DE shareholders approved Approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. at the 2026-05-13 meeting.

“Proposal 6. Approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. Votes For Votes Against Votes Abstained Broker Non-Votes 21,087,338 1,050,235 6,740 1,979,477 The Company’s stockholders approved an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5.”

ICU MEDICAL INC/DE shareholders approved Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%. at the 2026-05-13 meeting.

“Proposal 5. Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%. Votes For Votes Against Votes Abstained Broker Non-Votes 20,744,372 131,314 1,268,627 1,979,477 The Company’s stockholders approved the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%.”

ICU MEDICAL INC/DE shareholders approved Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. at the 2026-05-13 meeting.

“Proposal 4. Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. Votes For Votes Against Votes Abstained Broker Non-Votes 22,121,581 14,893 7,839 1,979,477 The Company’s stockholders approved the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions.”

ICU MEDICAL INC/DE shareholders approved Approve, on an advisory basis, the Company’s named executive officer compensation. at the 2026-05-13 meeting.

“Proposal 3. Approve, on an advisory basis, the Company’s named executive officer compensation. Votes For Votes Against Votes Abstained Broker Non-Votes 21,211,525 920,098 12,690 1,979,477 The Company’s stockholders approved, on an advisory basis, the Company’s named executive officer compensation.”

ICU MEDICAL INC/DE shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-05-13 meeting.

“Proposal 2. Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Votes Abstained Broker Non-Votes 23,862,197 255,744 5,849 0 The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

ICU MEDICAL INC/DE shareholders approved Election of directors at the 2026-05-13 meeting.

“Proposal 1. Election of directors. Name of Nominee Votes For Withheld Broker Non-Votes Vivek Jain 21,830,140 314,173 1,979,477 David C. Greenberg 21,838,112 306,201 1,979,477 Elisha W. Finney 21,875,087 269,226 1,979,477 David F. Hoffmeister 21,951,116 193,197 1,979,477 Donald M. Abbey 21,880,077 264,236 1,979,477 Laurie Hernandez 21,881,172 263,141 1,979,477 Kolleen T. Kennedy 21,881,304 263,009 1,979,477 The Company’s stockholders elected each of the director nominees to serve as a director until the next annual meeting of stockholders or until their respective successor is duly elected and qualified.”

UNITED BANKSHARES INC/WV shareholders approved Advisory approval of the compensation of United's named executive officers at the 2026-05-13 meeting.

“approved, on an advisory basis, the compensation of United's named executive officers”

UNITED BANKSHARES INC/WV shareholders approved Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-13 meeting.

“ratified the selection of Ernst & Young LLP, as the independent registered public accounting firm for the fiscal year ending December 31, 2026”

UNITED BANKSHARES INC/WV shareholders approved Election of fourteen directors for a one-year term expiring at the 2027 Annual Meeting at the 2026-05-13 meeting.

“The shareholders elected each of the fourteen (14) persons listed below as directors of the Company for a one-year term expiring at the 2027 Annual Meeting;”

Sylvamo Corp shareholders approved Approve on a non-binding advisory basis the compensation of the Company’s named executive officers ("NEOs") at the 2026-05-15 meeting.

“Proposal 3 – Approve on a non-binding advisory basis the compensation of the Company’s named executive officers (“NEOs”) The Company’s stockholders approved the compensation of the Company’s NEOs on a non-binding advisory basis.”

Sylvamo Corp shareholders approved Ratify the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm at the 2026-05-15 meeting.

“Proposal 2 – Ratify the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Sylvamo Corp shareholders approved Elect seven director nominees to the Company’s board of directors at the 2026-05-15 meeting.

“Proposal 1 – Elect seven director nominees to the Company’s board of directors The Company’s stockholders elected each of the individuals listed below as directors to serve until the next annual meeting of the Company and until their successors have been duly elected and qualified, or their earlier resignation.”

AAON, INC. shareholders approved Amendment to Articles of Incorporation to increase maximum size of Board from nine to eleven directors at the 2026-05-12 meeting.

“The voting results to approve the proposal to amend the Company's Articles of Incorporation to increase the maximum size of the Board from nine to eleven directors were as follows: For Against Abstain 72,417,102 359,357 38,856”

AAON, INC. shareholders approved Advisory vote on frequency of say-on-pay votes at the 2026-05-12 meeting.

“The voting results to approve, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers were as follows: One Year Two Years Three Years Abstain 64,209,213 44,436 1,297,811 168,992”

AAON, INC. shareholders approved Advisory resolution on compensation of named executive officers as set forth in the Proxy Statement at the 2026-05-12 meeting.

“The voting results to approve, on an advisory basis, a resolution on the compensation of the Company's named executive officers as set forth in the Proxy Statement were as follows: For Against Abstain Broker Non-Votes 63,496,580 2,148,606 75,266 7,094,863”

AAON, INC. shareholders approved Ratification of selection of Grant Thornton, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-12 meeting.

“The voting results with respect to the ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 were as follows: For Against Abstain Broker Non-Votes 71,064,229 1,692,536 58,550 —”

AAON, INC. shareholders approved Election of Directors at the 2026-05-12 meeting.

“The voting results with respect to the election of each director were as follows: Nominees For Against Abstain Broker Non-Votes Caron A. Lawhorn 63,511,892 2,173,737 34,823 7,094,863 Stephen O. LeClair 57,224,022 8,470,311 26,119 7,094,863 David R. Stewart 63,477,854 2,206,457 36,141 7,094,863”

ADTRAN Holdings, Inc. shareholders approved Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-12-31 meeting.

“ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 (Proposal 4)”

ADTRAN Holdings, Inc. shareholders approved Advisory Vote Regarding the Compensation of the Company's Named Executive Officers.

“approved, on an advisory basis, the compensation of the Company’s named executive officers (Proposal 3)”

ADTRAN Holdings, Inc. shareholders approved Amendment to Amended and Restated Certificate of Incorporation to Limit the Liability of Certain Officers as Permitted by Delaware Law and to Make Certain Other Changes to Section 7.1 Thereof.

“approved the Charter Amendment to limit the liability of certain officers as permitted by Delaware law and to make certain other changes to Section 7.1 thereof (Proposal 2)”

ADTRAN Holdings, Inc. shareholders approved Election of Directors.

“elected six directors to serve on the board of directors of the Company (the “Board”) for a one-year term expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified (Proposal 1)”

MANHATTAN ASSOCIATES INC shareholders approved Approval of the First Amendment to Manhattan Associates, Inc. 2020 Equity Incentive Plan at the 2026-05-14 meeting.

“4. Approval of the First Amendment to Manhattan Associates, Inc. 2020 Equity Incentive Plan 51,202,541 2,851,682 28,892 1,681,758”

MANHATTAN ASSOCIATES INC shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-05-14 meeting.

“3. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. 53,188,995 2,543,852 32,026 0”

MANHATTAN ASSOCIATES INC shareholders approved Non-binding resolution to approve the compensation of the Company's named executive officers. at the 2026-05-14 meeting.

“2. Non-binding resolution to approve the compensation of the Company's named executive officers. 48,346,043 5,701,372 35,700 1,681,758”

MANHATTAN ASSOCIATES INC shareholders approved Election of Class I Directors at the 2026-05-14 meeting.

“1. Election of Class I Directors Eddie Capel 2029 46,240,409 7,798,150 44,556 1,681,758 Charles E. Moran 2029 49,295,647 4,760,807 26,661 1,681,758 Linda T. Hollembaek 2029 40,736,566 13,311,873 34,676 1,681,758”

PATRICK INDUSTRIES INC shareholders approved To approve, in an advisory and non-binding vote, the compensation of the Company’s named executive officers for fiscal year 2025 at the 2026-05-14 meeting.

“Proposal 3 - To approve, in an advisory and non-binding vote, the compensation of the Company’s named executive officers for fiscal year 2025. For Against Abstain Broker Non-Votes 29,250,416 798,094 39,692 1,386,748”

PATRICK INDUSTRIES INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2026 at the 2026-05-14 meeting.

“Proposal 2 - Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2026. There were no broker non-votes. For Against Abstain 31,399,269 30,410 45,271”